Bibliographic Details
| Title: |
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO). |
| Authors: |
Roila, Fausto1 roila.fausto@libero.it, Fumi, Guglielmo1, Ruggeri, Benedetta2, Antonuzzo, Andrea3, Ripamonti, Carla4, Fatigoni, Sonia1, Cavanna, Luigi5, Gori, Stefania6, Fabi, Alessandra7, Marzano, Nicola8, Graiff, Claudio9, De Sanctis, Vitaliana10, Mirabile, Aurora11, Serpentini, Samantha12, Bocci, Chiara13, Pino, Maria Simona14, Cilenti, Giuseppina15, Verusio, Claudio16, Ballatori, Enzo17, on behalf of NICSO (Network Italiano per le Cure di Supporto in Oncologia) |
| Source: |
Supportive Care in Cancer. Mar2019, Vol. 27 Issue 3, p1041-1047. 7p. |
| Subject Terms: |
*FATIGUE (Physiology), *CANCER patients, *QUALITY of life, *CANCER treatment, *TREATMENT effectiveness, *EXERCISE & psychology, *ANXIETY, *MENTAL depression, *EXERCISE therapy, *QUESTIONNAIRES, *TUMORS, *DISEASE prevalence, *CROSS-sectional method, *DISEASE complications, *THERAPEUTICS |
| Geographic Terms: |
ITALY |
| Abstract: |
Background: Fatigue is one of the most distressing symptoms of cancer patients. Its characteristics and impact on quality of life have not been fully explored and treatment of cancer-related fatigue in Italian oncological centers has not been codified.Methods: A cross-sectional study was carried out on all patients attending for any reason the 24 participating centers in two non-consecutive days. Patients with fatigue filled out the Brief Fatigue Inventory (BFI) questionnaire and reported any pharmacological or non-pharmacological treatment for fatigue.Results: From October 2014 to May 2015, 1394 cancer patients agreed to participate in the study. Fatigue was referred by 866 (62.1%) of patients; its duration was > 4 months in 441 patients (50.9%). In the investigators' opinion, the most important (probable or almost sure) determinants of fatigue were reduced physical activity (271 patients), anxiety (149), pain (131), insomnia (125), anemia (123), and depression (123). Fatigue of moderate/severe intensity was reported by 43%/29.2% of patients, while usual fatigue in the last 24 h by 45%/33.1%, and the worst fatigue in the last 24 h by 33%/54.8%, respectively. Concerning the impact on quality of life, fatigue interfered moderately/severely with general activity in 30.8%/38.6% of patients, with mood in 26.1%/32.8%, with the ability to work in 27.9%/35.6%, with normal work in 26.7%/38.9%, with relationships with others in 21%/23.4% and with the ability to amuse themselves in 22.2%/33.1%. Only 117/866 patients (13.5%) received a pharmacological treatment represented by a corticosteroid in 101 patients (86.3%) while 188 patients (21.7%) received a non-pharmacological treatment such as physical exercise (120 patients, 63.8%) and various alimentary supplements (52 patients, 27.6%).Conclusions: Cancer-related fatigue is frequently reported by oncological patients; its intensity and impact on quality of life is relevant. [ABSTRACT FROM AUTHOR] |
|
Copyright of Supportive Care in Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
